$MJNA Wow quite a group an impressive folks at t
Post# of 18226
[b]$MJNA[/b] Wow quite a group an impressive folks at the helm of this one!!!
[b]Leadership[/b]
The Medical Marijuana Inc. (MJNA) team is made up of a diverse group of highly skilled professionals in their respected fields. Each individual who makes up the corporate structure of MJNA plays an integral part of the company’s day to day operation and overall success. MJNA believes for a company to not merely succeed but thrive in any economic and political environment you must first have the right people on the team, make sure they are in the right position, and allow them to operate with integrity and an entrepreneurial spirit.
The MJNA executive team work with industry and world authorities on cannabinoid based science and technologies to source, evaluate, acquire and develop value added companies and products. Each of the entities that make Medical Marijuana Inc.’s structure has a clearly defined purpose as it relates to an individual market, consumer or partner need. By utilizing these different facets, MJNA is able to provide an unparalleled platform of businesses that are unique among industry competitors. The professionals at MJNA are dedicated to “keeping it simple”. In an industry that has ever changing economic, political and scientific climate, its MJNA’s team’s ability to do just that that sets it apart.
Board of Directors
Michelle Sides
Chairman
Ted Caligiuri
Director
Gideon Wolf
Director
David Farrand
Director
Tripp Keber
Director
Executive Management
Ted Caligiuri
Interim President and CEO
Michelle Sides
Chief Operating Officer
Chairman
Tripp Keber
President, RDH Licensing
Chuck Smith
Chief Operating Officer, RDH
Babak R. Ghalili
Business Development Director
Dr. Philip A. Van Damme
Director, Canchew Biotechnologies
Dr. George E. Anastassov
Director, Canchew Biotechnologies
Lekhram Changoer
Director, Canchew Biotechnologies
Advisory Committees
Risk Management Committee
Vernon Darrimon
Agricultural Committee
Gideon Wolf
David Farrand
Medical Committee
Dr. Philip A. Van Damme
Dr. George E. Anastassov